Hospira Recalls Lots of Five Injections as FDA Re-Inspection Continues
Hospira has announced it is voluntarily recalling multiple lots of five different injections because of customer reports of faulty packaging and contamination.
Hospira has announced it is voluntarily recalling multiple lots of five different injections because of customer reports of faulty packaging and contamination.
Albemarle is adding new capacity at its manufacturing facility in Pennsylvania with a $30 million expansion.
As an FDA commissioned report on counterfeit drugs is released the potential to detect them may lie in a handheld API analyzing device.
A South African and Lonza joint project says issues in funding, competitiveness and green technologies have delayed construction of its API plant.
CRO Covance is teaming up with M2Gen’s cancer-focused database to increase its ability to match more patients in oncology trials based on their tumour profiles.
Glide Pharma says it is working to bring its Solid Dose Injector (SDI) to market in the next 2-3 years.